Citigroup
GOSS icon

Citigroup’s Gossamer Bio GOSS Stock Holding History

Citigroup’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08K Sell
6,569
-11,185
-63% -$3.12K ﹤0.01% 5406
2026
Q1 		$5.83K Sell
17,754
-31,458
-64% -$49.4K ﹤0.01% 5220
2025
Q4 		$153K Buy
49,212
+19,197
+64% +$54.8K ﹤0.01% 4119
2025
Q3 		$78.9K Sell
30,015
-37,419
-55% -$82.5K ﹤0.01% 4346
2025
Q2 		$82.9K Buy
67,434
+56,756
+532% +$61.9K ﹤0.01% 4502
2025
Q1 		$11.7K Buy
10,678
+10,675
+355,833% +$12.3K ﹤0.01% 5168
2024
Q4 		$3 Sell
3
-657,835
-100% -$564K ﹤0.01% 5793
2024
Q3 		$649K Buy
657,838
+157,835
+32% +$152K ﹤0.01% 3564
2024
Q2 		$450K Sell
500,003
-1,787,777
-78% -$1.34M ﹤0.01% 3465
2024
Q1 		$2.7M Buy
2,287,780
+582,344
+34% +$641K ﹤0.01% 2186
2023
Q4 		$1.56M Buy
1,705,436
+1,508,704
+767% +$1.11M ﹤0.01% 2456
2023
Q3 		$164K Buy
196,732
+194,768
+9,917% +$224K ﹤0.01% 3755
2023
Q2 		$2.36K Buy
1,964
+564
+40% +$702 ﹤0.01% 5268
2023
Q1 		$1.76K Sell
1,400
-1,204,145
-100% -$2.3M ﹤0.01% 5105
2022
Q4 		$2.62M Buy
1,205,545
+130,448
+12% +$1.07M ﹤0.01% 1847
2022
Q3 		$12.9M Buy
1,075,097
+200,311
+23% +$2.49M 0.01% 1014
2022
Q2 		$7.32M Buy
874,786
+808,377
+1,217% +$6.26M 0.01% 1309
2022
Q1 		$576K Sell
66,409
-86,376
-57% -$833K ﹤0.01% 3414
2021
Q4 		$1.73M Sell
152,785
-31,993
-17% -$380K ﹤0.01% 2741
2021
Q3 		$2.32M Buy
184,778
+6,660
+4% +$61.3K ﹤0.01% 2417
2021
Q2 		$1.45M Sell
178,118
-39,515
-18% -$343K ﹤0.01% 2939
2021
Q1 		$2.01M Buy
217,633
+200,077
+1,140% +$2.02M ﹤0.01% 2480
2020
Q4 		$170K Buy
17,556
+10,889
+163% +$107K ﹤0.01% 5111
2020
Q3 		$83K Sell
6,667
-29,959
-82% -$397K ﹤0.01% 5254
2020
Q2 		$476K Buy
36,626
+1,068
+3% +$13.4K ﹤0.01% 4308
2020
Q1 		$361K Sell
35,558
-3,278
-8% -$42.8K ﹤0.01% 4186
2019
Q4 		$607K Buy
38,836
+36,845
+1,851% +$742K ﹤0.01% 4250
2019
Q3 		$33K Sell
1,991
-4,288
-68% -$85.3K ﹤0.01% 6401
2019
Q2 		$140K Buy
6,279
+3,218
+105% +$61.6K ﹤0.01% 5568
2019
Q1 		$66K Buy
+3,061
New +$63.8K ﹤0.01% 6105

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Citigroup's GOSS Position: Q2 2026 in Review

Citigroup reduced its Gossamer Bio (GOSS) stake by 63% in Q2 2026, selling an estimated $3.12K and leaving 6,569 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #5406.

Citigroup first reported a position in GOSS in Q1 2019 and has held it in 30 quarters since. The position peaked at $12.9M in Q3 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Citigroup held 6,569 shares of Gossamer Bio worth $1.08K as of Q2 2026.
  • Citigroup sold 11,185 Gossamer Bio shares in Q2 2026, an estimated $3.12K.
  • Gossamer Bio made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5406 holding.
  • Citigroup first reported a position in Gossamer Bio in Q1 2019 and has held it in 30 quarters since.
  • Citigroup's Gossamer Bio position peaked at $12.9M in Q3 2022.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.